01—Abstract
Summary
Summary of the 10-Q filed May 1, 2025. Cited figures are marked; the original filing is the authoritative source.
IDEX Corporation's first quarter 2025 Form 10-Q reports net sales of $814.3 milliona, up 2% from $800.5 million a year earlier, while organic sales decreased 1%, reflecting lower volumes in parts of Fluid & Metering Technologies and Health & Science Technologies, partly offset by targeted growth initiatives and price capture.
Diluted EPS attributable to IDEX was $1.26b versus $1.60, and the filing states adjusted diluted EPS was $1.75, down 7%. Operating income fell to $142.0 million from $161.2 million, driven by $17.5 million of restructuring expenses and asset impairments (versus $1.1 million) tied to 2025 severance actions, and by higher interest expense of $16.1 million from debt used to fund the Mott acquisition. Gross margin improved to 45.3% from 44.6%.
Cash generation weakened in the quarter. Operating cash flow was $105.7 millionc compared with $156.6 million, and free cash flow was $91.4 million compared with $136.6 million, largely due to higher inventory investment and interest payments. The company repurchased $50.0 million of stock and repaid $30.2 million on its Revolving Facility, leaving $249.0 million drawn and about $548.0 million of net availability.
Cash and cash equivalents were $594.1 milliond at March 31, 2025, and the company reported compliance with its financial covenants, with an interest coverage ratio of 14.08 to 1 and a leverage ratio of 2.22 to 1. Management states it expects the potential impact of tariffs and trade policy changes to be largely mitigated by price increases and cost reductions, and says short-cycle order patterns have not been discernibly disrupted to date. The filing also notes that the company expects an additional $3.5 million to $7.5 million of restructuring charges for the remainder of 2025.
02—Key points
Key Highlights
- Net sales rose 2% to $814.3 million, but organic sales declined 1%, with the increase driven by the Mott acquisition.
- Diluted EPS attributable to IDEX was $1.26, down from $1.60; adjusted diluted EPS was $1.75 versus $1.88 in the prior-year period.
- Operating income decreased to $142.0 million from $161.2 million, reflecting $17.5 million of restructuring expenses and asset impairments.
- Gross margin improved to 45.3% from 44.6%, supported by operational productivity and price/cost.
- Operating cash flow fell to $105.7 million from $156.6 million; free cash flow was $91.4 million versus $136.6 million.
- The company repurchased $50.0 million of common stock and had $489.7 million of share repurchase authorization remaining at March 31, 2025.
- Covenant compliance was maintained, with an interest coverage ratio of 14.08 to 1 and a leverage ratio of 2.22 to 1.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q1 FY2025, Idex kept $0.12.
- Revenue$814.3M100.0%
- Cost of revenue−$445.4M54.7%
- Gross profit$368.9M45.3%
- Operating costs−$226.9M27.9%
- Operating income$142.0M17.4%
- Interest, other & tax−$46.5M5.7%
- Net income$95.5M11.7%
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2025filed May 1, 2025Financial Statements
Q1 FY2025 against Q1 FY2024
| Line item | Q1 FY2025Q1 FY2024 | Change |
|---|---|---|
| Revenue | $814.30M$800.50M | +1.7% |
| Cost of Revenue | $445.40M$443.10M | +0.5% |
| Gross Profit | $368.90M$357.40M | +3.2% |
| SG&A Expenses | $209.40M$195.10M | +7.3% |
| Operating Income | $142.00M$161.20M | −11.9% |
| Net Income | $95.50M$121.40M | −21.3% |
| EPS (Basic) | $1.26$1.60 | −21.3% |
| EPS (Diluted) | $1.26$1.60 | −21.3% |
| Shares Outstanding (Basic) | 75.70M75.70M | 0.0% |
| Shares Outstanding (Diluted) | 75.80M75.90M | −0.1% |
05—Questions
Frequently Asked Questions
Why did earnings per share decline despite higher sales?
Diluted EPS fell to $1.26 from $1.60 mainly because operating income declined to $142.0 million from $161.2 million. Restructuring expenses rose to $17.5 million from $1.1 million, and interest expense increased to $16.1 million from $9.4 million due to borrowings used to fund the Mott acquisition. The filing also notes the absence of discrete one-time tax benefits in the first quarter of 2024.
What is driving the drop in operating cash flow?
The filing attributes the decrease in operating cash flow to $105.7 million from $156.6 million primarily to higher investment in operating working capital, driven by inventory purchases to support planned production, and higher interest payments on the 4.950% Senior Notes issued in the third quarter of 2024 to fund the Mott acquisition.
What is the outlook regarding tariffs and trade policy?
Management expects the potential unfavorable impact of tariffs and changes to global trade policies on consolidated results to be largely mitigated by price increases and cost reduction. It states that short-cycle order patterns have not been discernibly disrupted to date, but continued uncertainty may further pressure volumes across its markets.
How much liquidity does the company have?
At March 31, 2025, IDEX had $594.1 million of cash and cash equivalents, of which $470.4 million was held outside the United States, and $548.0 million of net availability under its $800.0 million Revolving Facility after $249.0 million of borrowings and $3.0 million of letters of credit. The company states that current cash, operating cash flow and Revolving Facility availability are sufficient to meet its cash requirements for the foreseeable future.
What restructuring actions did the company take this quarter?
During the first quarter of 2025, IDEX incurred severance costs of $17.5 million related to organizational changes designed to connect scalable groups of businesses, which reduced headcount and eliminated certain management layers. The company expects an additional $3.5 million to $7.5 million of restructuring charges for severance related to these actions during the remainder of 2025.
06—Continue